SEC Form 4 · accession 0001654954-19-000380
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary A. Gelbfish
Director
Period of report
Jan 10, 2019
Accepted (ET)
Jan 11, 2019 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | Jan 10, 2019 | A | 12,500 | — | A | 2,654,871 | D | |
| Common StockF2 | holding | — | — | — | 14,000 | I | Landmark Foundation |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F3 | $1.66 | Jan 10, 2019 | A | 75,000 | A | — | Jan 10, 2029 | Common Stock | 75,000 | 75,000 | D |
| Stock Option (Right to Buy Common Stock)F4 | $0.57 | holding | — | — | — | — | Feb 16, 2028 | Common Stock, $0.001 par value per share | 40,000 | 40,000 | D |
| Stock Option (Right to Buy Common Stock)F5 | $0.37 | holding | — | — | — | — | Aug 3, 2027 | Common Stock, $0.001 par value per share | 75,000 | 75,000 | D |
| Series C-3 Non-Voting Convertible Preferred StockF6 | — | holding | — | — | — | Jan 8, 2014 | — | Common Stock, $0.001 par value per share | 500,000 | 500,000 | D |
| Warrant (Right to Purchase Common Stock) | $0.90 | holding | — | — | — | Jan 8, 2015 | Jan 1, 2020 | Common Stock, $0.001 par value per share | 250,000 | 250,000 | D |
Explanation of responses
- F1These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board.
- F2Held by Landmark Foundation, of which Dr. Gelbfish and his wife are trustees.
- F3These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
- F4These options were granted on 2/16/2018. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F5These options vest as follows: 1/3 on August 3, 2017, an additional 1/3 on August 3, 2018, and the remaining 1/3 on August 3, 2019.
- F6The conversion ratio is equal to the stated value of $10.00 divided by the conversion price of $1.00. The Series C-3 Non-Voting Convertible Preferred Stock is perpetual.